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ABSTRACT A label-free biosensing strategy for amoxicillin (AX) allergy diagnosis based on 
the combination of novel dendrimer-based conjugates and a recently developed nanoplasmonic 
sensor technology is reported. Gold nanodisks were functionalized with a custom-designed thiol-
ending- polyamido-based dendron (d-BAPAD) peripherally decorated with amoxicilloyl (AXO) 
groups (d-BAPAD-AXO) in order to detect specific IgE generated in patient’s serum against this 
antibiotic during an allergy outbreak. This innovative strategy, which follows a simple one-step 
immobilization procedure, shows exceptional results in terms of sensitivity and robustness, 
leading to a highly-reproducible and long-term stable surface which allows achieving extremely 
low limits of detection. Moreover, the viability of this biosensor approach to analyze human 
biological samples has been demonstrated by directly analyzing and quantifying specific anti-AX 
antibodies in patient’s serum without any sample pretreatment. An excellent limit of detection 
(LoD) of 0.6 ng/mL (i.e. 0.25 kU/L) has been achieved in the evaluation of clinical samples 
evidencing the potential of our nanoplasmonic biosensor as an advanced diagnostic tool to 
quickly identify allergic patients. The results have been compared and validated with a 
conventional clinical immunofluorescence assay (ImmunoCAP test), confirming an excellent 
correlation between both techniques. The combination of a novel compact nanoplasmonic 
platform and a dendrimer-based strategy provides a highly sensitive label free biosensor 
approach with over two times better detectability than conventional SPR. Both the biosensor 
device and the carrier structure hold great potential in clinical diagnosis for biomarker analysis in 
whole serum samples and other human biological samples. 
 
Keywords: nanoplasmonic biosensor, gold nanodisks, dendrimer, allergy diagnosis, IgE 
quantification, serum clinical sample, label-free detection 
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1. Introduction 
Health and clinical care increasingly demand new modalities of diagnostic instrumentation 
which can satisfy strict requirements that conventional methods cannot provide. In this sense, 
decentralized reliable analysis with diagnostic platforms performed at patient bedside, or in 
primary care doctor‘s office, which are fast, sensitive and minimize sample manipulation is still 
needed. The development of these point-of-care (POC) devices could simplify disease diagnosis 
and could aid in following disease progression (or regression). Optical biosensors stand out 
among other configurations as the best candidates to fulfill POC requirements. They show 
exceptional potential for integration in portable lab-on-a-chip devices. They provide direct 
quantification of molecules in a real time and label-free manner (Estevez et al., 2012; Ligler, 
2008). Plasmonic sensors and Surface Plasmon Resonance (SPR) sensor in particular are 
currently routine analytical instruments in laboratories due to its simplicity, robustness and 
versatility (Homola, 2008). Some of the well-known SPR limitations, such as moderate 
sensitivity, limited throughput capabilities and difficult miniaturization can be surpassed by 
using nanoplasmonic-based biosensors (Estevez et al., 2014; Petryayeva and Krull, 2011; 
Sepúlveda et al., 2009), whose configuration is based on the localized surface plasmon resonance 
(LSPR) rather than conventional SPR. Basically, the LSPR is the localized oscillation of free 
electron charges of metallic nanostructures with a resonance wavelength (λLSPR) which is 
determined by their composition, size, shape, and the refractive index (RI) of the surrounding 
dielectrics. LSPR has emerged during last decade due to the eruption of a wide variety of 
plasmonic nanostructures. However despite its demonstrated potential, its applicability as 
biosensing devices has not been fully exploited and mainly proof-of-concepts are reported in the 
literature. Appropriate biofunctionalization of the nanostructures is crucial to take full advantage 
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of such sensitive devices and the complexity of this step may lie behind the lack of reported 
complete bioanalysis in contrast with the high amount of examples based on conventional SPR. 
New biofunctionalization strategies which ensure stable and reliable assays, which in addition 
reduce potential nonspecific adsorption, are always sought. In particular, initial coatings or 
modification of the surface using functional linkers that in turns allows further specific receptor 
attachment have a direct influence on the final performance. Besides proteins, which are 
commonly used as carrier structures, dendrimers have profiled themselves as attractive materials 
because of the inherent capabilities conferred by their three-dimensional architecture (Astruc et 
al., 2010). Their structural homogeneity, controlled composition and multifunctionality make 
them unique for biomedical applications (Svenson and Tomalia, 2012), especially for drug 
delivery (Kesharwani et al., 2014) but also for biosensing (Fu and Li, 2013). Their use in 
immunochemistry has increased exponentially due to their interesting properties for the 
immobilization of biomolecules or small haptens. The globular-shaped poly(amido amine) 
PAMAM dendrimers (carrying amino groups in their structure) is the first and most extensively 
studied family (Trinchi and Muster, 2007). Conventional peptide carriers such as bovine serum 
albumin (BSA) or poly-L-lysine (PLL) usually lead to uncontrolled density and randomly 
distribution of the haptens in their structure, which can eventually induce reproducibility issues. 
In contrast, the regular geometry, stability, and high surface functionality of the dendrimers 
provide better control over the density and spacing of the immobilized molecules and also on the 
thickness of the overall receptor layer. 
Herein, we propose an unprecedented approach that combines the advantages of a recently 
reported novel and highly sensitive label-free nanoplasmonic biosensor based on gold nanodisks 
with a generation 2 (G2) BAPAD dendron-based structure in order to directly quantify specific 
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antibodies in human samples. The optical label-free sensor is based on a novel waveguiding 
mechanism occurring in nanoplasmonic structures composed out of short-range ordered arrays of 
gold nanodisks (Otte et al., 2011) which results not only in higher sensitivities to RI changes, but 
also in improved signal to noise ratios, assuring an overall significant improvement of the RI 
sensor performance. We have designed a compact read-out setup for the real time evaluation of 
the biomolecular interactions occurring in the functionalized nanostructures. 
Based on these grounds we have focused on the development of a highly sensitive and 
reproducible diagnostic tool for the quantitative detection of specific IgE antibodies in 
amoxicillin (AX) allergic patients. Current available diagnostic methods employed to assess 
subjects with an immediate allergic reaction include a complete clinical history plus in vivo skin 
tests or/and in vitro determination of specific IgEs in blood (Torres et al., 2003), whose 
production is triggered by the organism during an allergic outburst. Skin testing has been the 
most generalized approach. However this technique is invasive, painful (especially for children) 
and is not always appropriate particularly when the patient has suffered a severe allergic 
reaction. It requires the patient to temporarily stop medication, and results can be affected by 
skin condition. Solid phase immunoassays, such as the radioallergosorbent test (RAST) and 
subsequently the ImmunoCAP test have profiled themselves as best alternatives and are 
nowadays complementary in clinical diagnostics to the skin prick tests. Typically less sensitive 
than in-vivo skin tests (Chinoy et al., 2005), RAST is of a more qualitative nature and the results 
are usually expressed in a specific numerical scoring system (RAST scale from 0 to 6). On the 
other hand ImmunoCAP tests, based on fluorescent enzyme-labeled immunoassay (FEIA) 
(Mayorga et al., 2010), shows improved performance resulting from the high-binding capacity of 
the solid phase used to keep the allergen bound, which results in enhanced sensitivity. This 
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technology has been cleared by the Food and Drug Administration (FDA) to provide quantitative 
measurements of IgE concentration in blood, and is a validated method with a working range of 
0.35 – 100 kU/L (0.84-242 ng/mL), and a cutoff value of 0.35 kU/L (Alonso et al., 1995; Blanca 
et al., 2001). In fact, RAST scores have been correlated with IgE concentration determined with 
ImmunoCAP tests. As alternative to these conventional techniques, PAMAM dendrimers have 
been used as carrier structure to conjugate β-lactam antibiotics mimicking the behavior of 
protein-hapten conjugates. They have been able to recognize specific IgEs (Sánchez-Sancho et 
al., 2002), attached to cellulose disks (Montañez et al., 2008) or to silica nanoparticles (Vida et 
al., 2013) and used as solid phase in RAST assays of serum patient samples. However none of 
these studies provided quantitative information of IgE concentration. 
In this study we have developed not the whole dendrimer but a novel BAPAD-dendron structure 
as carrier molecule which can be easily transferred to (nano)plasmonic biosensor devices, 
allowing orthogonal coupling both to the gold surface and to amoxicillin molecules through the 
reactive amine groups in the outer shell. Using this strategy, very low concentrations of specific 
antibodies have been detected (LoD=0.6 ng/mL), that is better than the one achieved with the 
ImmunoCAP test. The appropriate surface coating minimizes nonspecific interactions which 
enables direct whole serum evaluation. A validation of the assay has been done with real serum 
samples from hospital patients and the excellent correlation with ImmunoCAP allergy test 
confirms the reliability and viability of our approach as a potential tool for fast and real-time 
diagnosis of drug allergy. 
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2. Materials and Methods 
2.1 Nanodisks preparation and optical setup description  
Short-ordered arrays of gold nanodisks (D = 100 nm, H = 20 nm (Ti/Au = 1/19 nm)) were 
fabricated on glass substrates via hole-mask colloidal lithography (HCL) (Fredriksson et al., 
2007). Before use, the substrates were cleaned by consecutive 1 min sonication cycles in 
acetone, ethanol and MilliQ water, dried with N2 stream and placed in an UV/O3 cleaner tor for 
20 min, after which they were rinsed with ethanol and water and dried with N2. Then, the 
substrates were clamped between a trapezoidal glass prism (n = 1.52) contacting the sample 
through RI matching oil (n ≈ 1.512) and a custom-made Delrin flow cell (volume = 4 µL), which 
is connected to a microfluidic system consisting on a syringe pump (New Era, NE-1000) with 
adjustable pumping speed that ensured a constant liquid flow and a manually operated injection 
valve (IDEX Health and Science, V-451). The biosensing surfaces were excited by a collimated 
halogen light source (HL-2000, Micro-pack) set in TE polarization for gold nanodisks (LSPR 
mode). The light reaches the substrates through the prism and the reflected light is collected and 
fiber-coupled to a CCD spectrometer (Ocean Optics, Jazz Module). The setup design involves a 
triangular platform with lateral sides designed at an angle of 80º with attached rails that 
incorporates the optical components, ensuring incoming and outgoing optical paths to remain 
constant at the desired angle (see Figure 1). Reflectivity spectra were acquired every 3 ms, and 
300 consecutive spectra were averaged to provide the spectrum to be analyzed. Tracking of the 
real-time resonance peak position was achieved via polynomial fit using a homemade readout 
software. 
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2.2 Surface functionalization and IgE detection  
Reduction of the disulfide bond in the PMA-AX dimer (0.25 mM in H2O) was carried out by 
reaction with 10 mM dithiothreitol (DTT; Sigma Aldrich) during 15 min under continuous 
agitation. The sample was immediately injected and flowed through the sensor surface at 15 
µL/min keeping H2O as running buffer. Blocking of PLL-g-PEG was carried out by injecting 0.5 
mg/mL PLL(20)-g[3.5]-PEG(2) (SuSoS AG) in HEPES 10 mM. This immobilization step and all 
subsequent measurements were performed in situ, by continuously monitoring the signal 
response in real time. 
After immobilization, PBST 0.5% (PBS + 0.5% Tween 20) was settled as running buffer. For 
optimization and assessment studies, different concentration of monoclonal anti-penicillin IgG 
antibody (Acris Antibodies) were diluted in PBST 0.5% and flowed over the functionalized 
surface at 25 µL/min. Regeneration of the surface was achieved by injecting 20 mM NaOH at 65 
µL/min. Total sample analysis were 30 min, considering the surface regeneration step. 
Calibration curves were fitted to a saturation total binding model. LoD were calculated as the 
concentration corresponding to the blank signal plus three times its standard deviation (SD), 
while the LoQ were determined as the concentration corresponding to the minimum measurable 
signal, set as the blank signal plus 10 times SD.  
2.3 Real samples analysis  
Antifouling cocktail (AFC) used for serum measurements consisted of 10 mM phosphate, 137 
mM NaCl, 2.7 mM KCl, 500 mM MgCl2, 2% Tween 20 and 2% of commercial human serum 
(Sigma-Aldrich). AFC buffer was kept in flow for 20 min before starting the measurements. 
Calibration curve for anti-penicillin monoclonal IgG in serum was performed using commercial 
human serum spiked with the antibodies. Calibration curve for anti-amoxicillin IgE was 
 9 
performed by serially diluting a serum sample with known concentration of specific IgE. Serum 
samples from allergic and non-allergic patients were extracted following standardized protocols 
by the Hospital de Málaga (Spain), and were analyzed with the ImmunoCAP test for amoxicillin 
IgE detection. Same clinical samples were directly flowed onto the functionalized surface with 
no previous pretreatment or dilution. 
 
3. Results and Discussion 
3.1 BAPAD-AXO conjugate 
BisAminoalkyl PolyAmide Dendrimers (BAPAD) dendrimers and dendrons have been designed 
in order to emulate protein-like structures. The complete synthetic pathway is described in the 
Supporting Information and it can be summarized in Scheme 1. It is based on iterative reactions 
that allow the growth of the dendrimer structure, in this case, up to generation 2. The strategy 
includes two steps: i) condensation between the core (cystamine), which incorporates the 
disulfide bridge that will be used to anchor to the gold surface, and the 3,3’-diazidopivalic acid 
(1) to obtain amide linked multi-azides; ii) reduction of the multi-azide structure to obtain the 
multi-amines, which then will be the reactive groups for the next generation of dendrimer. The 
strategy was repeated two times, in such a way that generation 2 (G2) dendrimers were obtained, 
having 8 amine groups in the outer shell. Then, with the aim of obtaining the dendrimeric-
antigen functionalized with the allergenic determinant responsible of the allergic reaction to 
amoxicillin, this epitope was covalently bound to the dendrimer’s periphery. D-BAPADG2 was 
reacted with amoxicillin at high pH, to ensure that the amine groups at its periphery were 
unprotonated, acting as nucleophilic positions that efficiently attack the electrophilic carbonyl 
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group of the beta-lactam antibiotic. Reaction conditions were optimized to obtain D-BAPADG2-
AXO with amoxicillin in all the reactive positions (8 antigenic determinants per structure). 
 
Scheme 1. DBAPADG2 synthetic pathway and coupling of amoxicillin 
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3.2 Nanoplasmonic biosensor platform 
Short-range ordered arrays of gold nanodisks (diameter D = 100 nm, height H = 20 nm, surface 
density F = 6-7%) were fabricated by hole-mask colloidal lithography (HCL) (Fredriksson et al., 
2007). In a recent study, we reported that these nanostructured substrates can sustain a novel in-
plane guided mode that can be excited in total internal reflection (Otte et al., 2011). Briefly, the 
in-plane LSPR excitation strongly enhances the polarizability of the nanodisks, creating an 
effective RI that is sufficiently large to support a guided electromagnetic mode inside this thin 
and sparse monolayer of nanostructures. This waveguided mode results not only in a large 
increase of the RI sensitivity, but also strongly improves the signal-to-noise ratio. Both effects 
assure an overall improved RI sensing performance that is up to an order of magnitude better 
than that of isolated non-interacting nanodisks. RI changes close to the nanostructure surfaces, 
such as the ones originating from biomolecular interactions are therefore much easier to detect. 
Hence, time-dependent monitoring of spectral LSPR peak displacements (ΔλLSPR) enables the 
extraction of real-time quantitative information related to the biomolecular interactions taking 
place (see Figure 1). 
Previous in-house studies demonstrated that the resulting sensing performance of these guided 
modes depends on both the nanodisks surface density (F) and the incidence angle of the light (θ) 
(Otte et al., 2011). Whereas the RI sensitivity increases as θ approaches 90 degrees, optimal 
mode excitation, which is characterized by light coupling efficiencies close to 100%, strongly 
depends on the value of F. Hence, for an optimized sensing performance, F needs to be precisely 
chosen such that optimal mode excitation occurs at angles where the sensitivity is maximized, 
that is, angles close to 90º. However, due to imposed restrictions of our measurement setup 
(divergence of a finite-sized collimated broadband light source used for mode excitation), the 
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largest possible incidence angle was restricted to θ=80º degrees. For this particular angle, 
optimal mode excitation is achieved when the nanodisk surface density is approximately F = 6-
7%. With this fact in mind, nanostructured substrates were fabricated with these surface 
occupancies, resulting in deep mode-specific reflectivity dips at λLSPR ≈ 750 nm. For these 
specific measurement conditions, a miniaturized system was devised, based on a triangular 
aluminum platform with lateral sides designed at an angle of θ = 80º (see Figure 1). This 
platform contains a custom-made flow cell and a specifically designed trapezoidal prism (θ=80º). 
Additionally, optical rails that are perpendicularly attached to it, are used for the assembly of all 
optical components necessary for the TE mode excitation and the collection of the reflected light. 
The designed optical platform has very small dimensions (all the optical components are 
mounted on a 20x20cm portable breadboard), exemplifying its facile miniaturization and 
potential portability. Bulk sensitivity experiments confirmed the expected improved sensing 
performance at this high angle when compared to a similar setup mounted on a platform 
designed at an incidence angle of θ=70º. Specifically, an approximately 4 times better sensitivity 
(ηB80º ≈ 375 nm RIU
-1
 vs ηB70º ≈ 100 nm RIU
-1
) was obtained (see Figure S1 in the Supporting 
Information, SI), confirming the enhanced sensitivity of the high-angle LSPR sensor platform. 
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Figure 1. Top: Schematic of the miniaturized nanoplasmonic biosensor. Bottom: (left) graph 
showing the resonance peak (photon counts vs. λ); (right) graph showing the shift of the 
resonance peak over time (ΔλLSPR of the minimum vs. time). 
3.3 Biosensor strategy: optimization and assessment 
In biosensing experiments, besides the inherent sensitivity imposed by the sensor, there are 
additional factors that are equally important to define the analytical sensitivity, the selectivity 
and the biosurface stability for a particular sensing assay. In our case, the achievement of an 
efficient immobilization onto the gold nanodisks is the most critical one. In general, surface 
modification of gold patterned surfaces requires conditions that assure specific and oriented 
binding onto the sensing areas (gold nanodisks) while avoiding non-specific binding of 
molecules to the substrate (glass). This can be achieved via a stepwise selective surface 
modification protocol with appropriate reagents, thereby exploiting the strong selectivity of gold 
for thiol-based compounds. For this reason, a dendron structure was designed and synthesized, 
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with a spacer arm bearing a thiol group on the core and amoxicilloyl groups (AXO) in its outer 
shell (d-BAPADG2-AXO conjugate, see Scheme 1 and Figure 2). This design allows a fast and 
simple functionalization onto gold surfaces in only two steps: (i) the reduction of the disulfide-
core of the dendrimer to create two thiol-functional symmetric dendrons, and (ii) their direct 
immobilization on the gold nanodisks by thiol chemisorption (see Figure 2). Using the d-
BAPADG2-AXO dendron, which incorporates a short thiol linker, a self-assembled layer is 
formed in a single-step chemisorption procedure, providing a well-ordered receptor layer over 
the gold nanodisks surface. In a separate step, SiO2 was independently modified by using poly-L-
lysine grafted PEG (PLL-g-PEG). This copolymer creates a brushed coating on SiO2 surfaces 
which has proven to successfully prevent and reduce nonspecific adsorption of proteins due to its 
hydrophilic properties (Marie et al., 2007; Soler et al., 2014). 
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Figure 2.  Schematic representation of the d-BAPADG2-AXO based biosensing strategy: (a) 
disulfide bond reduction with DTT and (b) direct immobilization on gold nanodisks by 
chemisorption and subsequent detection of specific IgE antibodies. 
The structure of the amoxicillin-conjugated dendrimer d-BAPADG2-AXO was designed for the 
detection of IgE antibodies specific for this antibiotic. The AX was coupled via the β-lactam ring 
opening, in such a way that the rest of the structure particular to this penicillin (the thiazolidine 
ring and the variable side chain characteristic for AX) would remain exposed. Ideally in order to 
develop the assay (i.e. to generate and optimize a calibration curve) the appropriate target should 
be IgEs obtained from patients, or alternatively, IgE obtained after an external intended 
production process. However, the standard antibody production protocols are usually directed 
towards the mechanisms based on IgG generation, which are the most abundant types in serum. 
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Given the difficulty of having specific IgE antibodies for amoxicillin, the evaluation and 
optimization of our biosensing approach was carried out with commercial anti-penicillin IgG 
antibodies. Although not exclusively specific for amoxicillin, but also for other β-lactam 
penicillins, these generic IgG antibodies are very useful to evaluate the behavior of the d-
BAPADG2-AXO coated surface and the viability of our proposed approach for detecting IgEs in 
serum.  
The dendron structure incorporating the target molecule on its outer shell was directly attached to 
the gold surface in a single step. This step was performed in situ by injecting the solution of d-
BAPADG2-AXO through the cell. The immobilization was therefore continuously monitored in 
real time. Efficient and stable attachment was achieved, observing higher signals as the 
conjugate concentration increased (see Figure S2 in SI). The immobilization step is 
concentration dependent and shows high reproducibility (CV ~ 5-6%, see Table S1 in SI) 
reaching maximum surface coverage without affecting antigen accessibility at a concentration of 
0.25 mM (see Figure 3a). Higher concentrations did not translate into higher signal, which may 
be a sign of steric hindrance resulting from a high density of conjugates on the surface. 
Specificity studies done with other IgGs and control proteins (such as BSA) resulted in 
negligible binding onto the d-BAPADG2-AXO functionalized surface (see Figure 3b), indicating 
a high degree of selectivity of the active surface. Moreover, d-BAPAD-based strategy provides 
robust and long-time stable receptor surface because of the strong binding mechanism implicated 
in the gold functionalization (i.e. thiol chemisorption). Regeneration of the functionalized surface 
with basic conditions (NaOH 20 mM) led to complete removal of the recognized antibodies after 
each assay while retaining the integrity of the receptor layer with good levels of reproducibility 
for more than 40 cycles (an example of antibody detection and complete regeneration is shown 
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in Figure S3 in the SI). Using the optimal d-BAPADG2-AXO concentration and IgG specific for 
amoxicillin a promising Limit of Detection (LoD) of 4 ng/mL (R
2
 = 0.9920) was determined. 
This detectability is better than the one obtained with a 70º angle LSPR sensor (7 ng/mL) and the 
one reached with conventional SPR (10 ng/mL) using the same immunoreagents (see Figure S4 
in the SI) which successfully confirms the better performance of our LSPR biosensor. 
 
Figure 3. (a) Calibration curves for anti-penicillin detection at different d-BAPADG2-AXO 
concentrations (0.05-0.5 mM) performed with 80º-nanoplasmonic sensor; (b) Specificity study 
for the d-BAPADG2-AXO based strategy: sensorgrams for the detection of specific anti-
penicillin antibody (black), nonspecific IgG antibody (purple) and bovine serum albumin (green) 
at 1 µg/mL; red dashed line indicates reference (background signal). Assays performed with 80º-
nanoplasmonic setup. 
Overall, the design of the dendron structure represents a substantial step forward compared with 
the strategies used so far based on conventional dendrimers (Altintas et al., 2012; Mark et al., 
2004; Pillet et al., 2013; Singh et al., 2009). In those cases, whole dendrimers were used as 
carriers in optical label-free biosensors, with the idea of increasing the immobilization capacity 
and enhancing the efficiency and stability of the modified surface. However, that approach 
requires extra steps to couple the dendrimers to the transducer surface (i.e. surface modification 
with a SAM and subsequent covalent attachment of the dendrimers) which considerably stretches 
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on the whole process and can in turn affect the overall reproducibility of the assay. We 
performed a comparison using a G2-PAMAM peripherally decorated with AXO and covalently 
attached over a modified gold nanodisk surface (experimental data is summarized in the SI) and 
we observed: (i) lower immobilization efficiency with worse reproducibility (ii) worse overall 
sensitivity (almost ~3 times higher LoD) (Figure S5 and Table S1 in SI). In the case of d-
BAPADG2-AXO dendron, the thiol-directed attachment and oriented immobilization allows 
site-specific attachment in a more reproducible way than with the covalent binding, leaving 
exposed the AXO groups and maximizing antibody binding. This confirms the capabilities of the 
thiol-based d-BAPADG2-AXO dendron as a carrier scaffold. 
3.4 Human samples analysis  
The main goal of any biosensor is the demonstration of its applicability for the detection of a 
substance of interest in real samples, and if the intended use is in the clinical field, the purpose 
would be the direct analysis of human fluids. In the case of label-free optical biosensors where 
the signal comes indirectly from the mass adsorbed on the surface, the main challenge is to avoid 
nonspecific adsorption that can lead to false positive signals. There is a wide interest in 
developing biofunctionalization and assay strategies to prevent or minimize nonspecific binding 
onto the sensor surface. The use of PEGylated compounds together with the addition of 
surfactants to the buffer have proven to reduce the adsorption of proteins on different substrates 
(Krishnan et al., 2008). In this work, our goal was the analysis of serum samples from patients 
with allergy. We combined the use of PLL-g-PEG, that selectively binds to the glass and creates 
a hydrophilic layer which passivates the non-sensitive areas of the nanostructured substrates 
(Marie et al., 2007), with the use of an antifouling running solution that minimizes the 
nonspecific adsorption. Most common additives in antifouling cocktails are non-ionic detergents 
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(e.g. Tween 20), due to their ability to disrupt ionic and hydrophobic biomolecule-surface bonds, 
or blocking agents such as BSA, non-fat dry milk, fish gelatin or whole serum. We performed a 
study of different buffer formulations in order to minimize the background signal produced by 
undiluted human serum, testing several concentrations of Tween 20 and different additives (BSA 
and common control serum). Best results were obtained when combining PLL-g-PEG coated 
surfaces and an antifouling cocktail consisting of PBS with 2% of Tween 20 and 2% of 
commercial serum as running fluid (see Figure 4). The background signal observed under these 
conditions was low enough and highly reproducible (standard deviation below 0.01 nm) to 
permit reliable detection of antibodies in whole serum, therefore assuming a constant 
background for all measurements. The calibration curve was obtained by injecting undiluted 
commercial serum spiked with anti-penicillin IgG antibodies at different concentration (0.025 – 
2 µg/mL) (see Figure 5a). A LoD of 8 ng/mL was achieved, while the limit of quantitation (LoQ) 
was set at 16 ng/mL. The LoD was slightly higher than for standard buffer conditions due to the 
contribution of the constant background. However the profile of the curve was analogous 
proving that serum matrix does not significantly affect the analysis performance as long as the 
background nonspecific signal is kept constant. 
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Figure 4. Background signal of whole serum onto the sensor surface blocked with PLL-g-PEG 
at different composition of running buffer: PBS + Tween 20 (0.5 – 2%) + serum (0.5 – 2%). 
Inset graph shows the influence of the PLL-g-PEG on the background signal by representing the 
nonspecific adsorption for the best running buffer conditions (PBS (2% Tween 20 and 2% 
serum) on surfaces lacking PLL-g-PEG. 
With these optimal conditions selected for the evaluation of whole serum, direct detection of real 
samples from patients was attempted. Due to the inherent differences between the IgGs used in 
the optimization step and the real target to measure (i.e. human specific IgE produced by the 
organism towards amoxicillin) we decided to perform a calibration curve directly with a serum 
sample from a patient, whose specific IgE concentration was known ([IgE] = 47.19 ng/mL 
determined with the ImmunoCAP assay). The sample was serially diluted with commercial 
serum and the curve was obtained using the previously optimized conditions for nonspecific 
adsorption minimization (see Figure 5b). Using IgEs as standard, a LoD of 0.6 ng/mL was 
achieved (more than one order of magnitude lower) and the LoQ resulted in 2.2 ng/mL. This 
enhancement of the analytical sensitivity as compared to the previous values obtained with the 
anti-penicillin IgG (see Figure 5a) can be due to: (i) structural differences between IgG and IgE. 
IgE antibodies have a molecular weight that is approximately 1.3 times higher than IgGs (i.e. 
MWIgE ≈ 200 kDa, MWIgG ≈ 150 kDa), and since in plasmonic biosensors the mass plays a 
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determinant role in the response, the output signal may be different; and (ii) a higher affinity for 
the antibodies produced by the human body against amoxicillin would be expected, as compared 
to the IgGs produced in mouse. Moreover, the IgG used as standard has a broad specificity 
towards the thiazolidine ring and, therefore, for several penicillins (i.e. it was produced using a 
conjugate of benzylpenicillin, presumably through β-lactam ring opening). Therefore, a lower 
affinity compared to the IgEs directly generated against amoxicillin would probably lead to 
lower signals at the same concentration. Overall, the improvement of the sensitivity when using 
the appropriate target clearly confirmed the higher natural affinity of the IgE against amoxicillin 
than the one of commercially produced IgG. 
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Figure 5. (a) Anti-penicillin IgG calibration curves in PBST (blue) and whole serum (black); (b) 
Amoxicillin-specific IgE calibration curve in serum samples. 
 
The viability of the proposed biosensor methodology for allergy diagnosis was assessed by 
evaluating real clinical samples from allergic patients and quantified them using the IgE 
calibration curve. Non-pretreated and undiluted serum samples from amoxicillin allergic patients 
(S1, S3 and S5) and healthy donors (S2, S4 and S6) were directly flowed over the functionalized 
sensor surface by duplicate. Quantification of the specific IgE antibodies was carried out by 
interpolating the values of the signals in the calibration curve (see Figure 5b). Table 1 lists and 
 23 
compares the results of the analysis obtained with the nanoplasmonic biosensor (mean ± SD) and 
with the ImmunoCAP test performed at the hospital. All recoveries ranged between 96–115% 
evidencing good correlation between both diagnostic techniques. The concentration values 
obtained for each sample were also plotted and fitted to a linear regression function (see Figure 
6). As can be observed, the excellent linearity (R
2
 = 0.9988) and correlation between both 
approaches (slope = 1.173) corroborate the accuracy of dendrimer-based nanoplasmonic 
biosensor to quantify IgE antibodies in whole serum. 
 
Figure 6. Accuracy studies performed with the nanoplasmonic biosensor. The graph shows the 
correlation between the values obtained with the sensing platform and the ImmunoCAP assay. 
Data shown correspond to the average of 2 replicates. Dotted line corresponds to a perfect 
correlation (slope = 1). 
 
 
 
 24 
Table 1. Clinical serum samples analysis determined by ImmunoCAP assay and the 
nanoplasmonic biosensor  
Sample 
anti-AX IgE Concentration  
% Recovery 
ImmunoCAP (kUIgE/L)
a
 ImmunoCAP (ng/mL)
*
 Nanobiosensor (ng/mL) 
S1 215F11 14.5 35.09 40.39 ± 1.3 115 
S2 768F10 ND
b
  ND (< 0.84) 0.95 ± 0.35 113 
S3 1103F09 3.53 8.54 9.00 ± 0.58 105 
S4 1732F09 ND  ND (< 0.84) 0.69 ± 0.16 100 
S5 29F04 3.4 8.23 7.87 ± 0.27 96 
S6 2F06 ND  ND (< 0.84) ND (< 0.6) 100 
a
 1 kUIgE/L = 2.42 ng/mL (Winter et al., 2000) 
b
 ND: not detected (below detection limit of the assay of 0.35 kUIgE/L) 
 
4. Conclusions 
We present an innovative methodology for drug allergy diagnosis by direct quantification of 
amoxicillin specific IgE antibodies in serum using a novel nanoplasmonic biosensor device. We 
have designed and developed a complete biosensing strategy by combining specifically 
synthesized dendron-based amoxicillin conjugates with gold nanostructured surfaces leading to a 
fast, reliable, highly sensitive and label-free analysis. The thiol-functional dendron (d-
BAPADG2) allows simple and robust gold functionalization creating a regular and reproducible 
recognition layer. The d-BAPADG2-AXO dendron shows improved analytical features 
compared to PAMAM dendrimers in terms of sensitivity and surface reproducibility, achieving 2 
times lower limits of detection. Moreover, the use of PLL-g-PEG for blocking the inert areas 
provides an antifouling coating that reduces the nonspecific adsorptions and minimizes the 
background signal when evaluating whole serum. The selectivity and reliability has been 
demonstrated by performing a calibration curve with undiluted serum samples spiked with anti-
penicillin IgG antibodies. Results showed that the serum components did not interfere in the 
antibody recognition process as similar sensitivity was achieved. To validate the proposed 
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methodology a calibration curve was carried out with human specific amoxicillin IgE antibodies, 
revealing a notable increase of the sensitivity associated to the extremely high affinity of IgEs for 
the specific allergen. LoD was set at 0.6 ng/mL in whole serum. Finally, clinical samples from 
allergic patients and negative control samples were tested with the nanoplasmonic biosensor and 
the results were compared to those determined with an ImmunoCAP assay. An excellent 
accuracy was observed after obtaining recoveries in the range 96 – 115%, with an exceptional 
linear correlation with the conventional immunoassay. The outstanding levels of sensitivity of 
the biosensor nanoplasmonic platform allow direct measurement of human samples without any 
kind of pretreatment or preconcentration of the sample with a total analysis time of 15 min. The 
excellent features of the nanoplasmonic biosensor and the dendron-based conjugates represent an 
attractive alternative as a fast and user-friendly diagnostic tool for clinical analysis and for 
obtaining quantitative data of amoxicillin allergy. Moreover, the overall strategy can be virtually 
adapted to detect other clinical biomarkers or any kind of target, simply by conjugating them to 
the dendron structure. The presented biosensing methodology holds great promise to improve 
biomarkers detection directly in human samples and constitutes a potentially useful tool for 
clinical diagnosis practice and for the development of point-of-care devices. 
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Highlights 
 A thiol-ending dendron has been specifically designed as carrier molecule 
 Amoxicillin(AX)-coated dendron used as receptor in a novel nanoplasmonic biosensor 
 Direct label-free quantification of AX specific IgEs in serum using the biosensor 
 Antifouling surface conditions allow whole patient serum analysis without dilution 
 Validation with standard immunoassay and real patient samples confirms the accuracy 
 
